Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The New Jersey Neuroscience Institute (NJNI) is a premier clinical and research center located at JFK University Medical Center in Edison, New Jersey. As a division of Hackensack Meridian Health, the institute specializes in the diagnosis and treatment of complex neurological and neurosurgical disorders, including stroke, epilepsy, and movement disorders. NJNI is recognized as a leader in clinical research, serving as a major site for global clinical trials evaluating novel pharmacological therapeutics and advanced medical devices. The institute combines high-volume clinical practice with academic excellence, maintaining strong affiliations for medical education and specialized residency programs. Its multidisciplinary team utilizes cutting-edge technologies such as Gamma Knife radiosurgery and deep brain stimulation to provide comprehensive neurosurgical care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Jersey Neuroscience Institute.